389 related articles for article (PubMed ID: 28784930)
1. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
[TBL] [Abstract][Full Text] [Related]
2. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
[TBL] [Abstract][Full Text] [Related]
3. Live imaging of Yersinia translocon formation and immune recognition in host cells.
Rudolph M; Carsten A; Kulnik S; Aepfelbacher M; Wolters M
PLoS Pathog; 2022 May; 18(5):e1010251. PubMed ID: 35604950
[TBL] [Abstract][Full Text] [Related]
4. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
5. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
Kwuan L; Adams W; Auerbuch V
Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
[TBL] [Abstract][Full Text] [Related]
6. Type III secretion translocon assemblies that attenuate Yersinia virulence.
Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
[TBL] [Abstract][Full Text] [Related]
7. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system.
Brodsky IE; Palm NW; Sadanand S; Ryndak MB; Sutterwala FS; Flavell RA; Bliska JB; Medzhitov R
Cell Host Microbe; 2010 May; 7(5):376-87. PubMed ID: 20478539
[TBL] [Abstract][Full Text] [Related]
8. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
Adams W; Morgan J; Kwuan L; Auerbuch V
Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
[TBL] [Abstract][Full Text] [Related]
9. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V; Golenbock DT; Isberg RR
PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
[TBL] [Abstract][Full Text] [Related]
10. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
Francis MS; Wolf-Watz H
Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
[TBL] [Abstract][Full Text] [Related]
11. Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles.
Coleman MA; Cappuccio JA; Blanchette CD; Gao T; Arroyo ES; Hinz AK; Bourguet FA; Segelke B; Hoeprich PD; Huser T; Laurence TA; Motin VL; Chromy BA
PLoS One; 2016; 11(3):e0150166. PubMed ID: 27015536
[TBL] [Abstract][Full Text] [Related]
12. Measurement of Yersinia Translocon Pore Formation in Erythrocytes.
Costa TRD; Francis MK; Farag SI; Edgren T; Francis MS
Methods Mol Biol; 2019; 2010():211-229. PubMed ID: 31177441
[TBL] [Abstract][Full Text] [Related]
13. The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function.
Thorslund SE; Edgren T; Pettersson J; Nordfelth R; Sellin ME; Ivanova E; Francis MS; Isaksson EL; Wolf-Watz H; Fällman M
PLoS One; 2011 Feb; 6(2):e16784. PubMed ID: 21347310
[TBL] [Abstract][Full Text] [Related]
14. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
16. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
Edqvist PJ; Aili M; Liu J; Francis MS
Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
[TBL] [Abstract][Full Text] [Related]
17. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
[TBL] [Abstract][Full Text] [Related]
18. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
Harmon DE; Murphy JL; Davis AJ; Mecsas J
J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
[TBL] [Abstract][Full Text] [Related]
19. Macrophage innate immune responses delineate between defective translocon assemblies produced by
Farag SI; Francis MK; Gurung JM; Wai SN; Stenlund H; Francis MS; Nadeem A
Virulence; 2023 Dec; 14(1):2249790. PubMed ID: 37621095
[TBL] [Abstract][Full Text] [Related]
20. Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function.
Solomon R; Zhang W; McCrann G; Bliska JB; Viboud GI
PLoS One; 2015; 10(3):e0120471. PubMed ID: 25807250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
